Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | TG(44:1) | cPLA2i | 1.0 | BCD110605C28 | 0.05 | pmol/sample |
| - | TG(44:1) | cPLA2i | 1.0 | BCD110605C30 | 1.49 | pmol/sample |
| - | TG(44:1) | cPLA2i | 1.0 | BCD110605C29 | 1.22 | pmol/sample |
| - | TG(44:1) | cPLA2i | 20.0 | BCD110605C64 | 4.43 | pmol/sample |
| - | TG(44:1) | cPLA2i | 20.0 | BCD110605C66 | 0.33 | pmol/sample |
| - | TG(44:1) | cPLA2i | 20.0 | BCD110605C65 | 4.06 | pmol/sample |
| - | TG(44:1) | PLDi | 1.0 | BCD110605C16 | 0.16 | pmol/sample |
| - | TG(44:1) | PLDi | 1.0 | BCD110605C17 | 1.79 | pmol/sample |
| - | TG(44:1) | PLDi | 1.0 | BCD110605C18 | 1.57 | pmol/sample |
| - | TG(44:1) | PLDi | 20.0 | BCD110605C54 | 2.43 | pmol/sample |
| - | TG(44:1) | PLDi | 20.0 | BCD110605C52 | 2.96 | pmol/sample |
| - | TG(44:1) | PLDi | 20.0 | BCD110605C53 | - | pmol/sample |
| - | TG(44:1) | KDO+cPLA2i | 1.0 | BCD110605C32 | 0.9 | pmol/sample |
| - | TG(44:1) | KDO+cPLA2i | 1.0 | BCD110605C31 | 0.45 | pmol/sample |
| - | TG(44:1) | KDO+cPLA2i | 1.0 | BCD110605C33 | 0.8 | pmol/sample |
| - | TG(44:1) | KDO+cPLA2i | 20.0 | BCD110605C68 | 1.1 | pmol/sample |
| - | TG(44:1) | KDO+cPLA2i | 20.0 | BCD110605C69 | 0.84 | pmol/sample |
| - | TG(44:1) | KDO+cPLA2i | 20.0 | BCD110605C67 | 1.36 | pmol/sample |
| - | TG(44:1) | KDO+PLDi | 1.0 | BCD110605C19 | 0.22 | pmol/sample |
| - | TG(44:1) | KDO+PLDi | 1.0 | BCD110605C20 | 1.16 | pmol/sample |
| - | TG(44:1) | KDO+PLDi | 1.0 | BCD110605C21 | 2.08 | pmol/sample |
| - | TG(44:1) | KDO+PLDi | 20.0 | BCD110605C56 | - | pmol/sample |
| - | TG(44:1) | KDO+PLDi | 20.0 | BCD110605C57 | 0.93 | pmol/sample |
| - | TG(44:1) | KDO+PLDi | 20.0 | BCD110605C55 | 1.64 | pmol/sample |
| - | TG(44:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C37 | 0.5 | pmol/sample |
| - | TG(44:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C38 | 1.55 | pmol/sample |
| - | TG(44:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C39 | 1.48 | pmol/sample |
| - | TG(44:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C74 | - | pmol/sample |
| - | TG(44:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C75 | 0.12 | pmol/sample |
| - | TG(44:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C73 | 2.03 | pmol/sample |
| - | TG(44:1) | KDO+ATP+PLDi | 1.0 | BCD110605C25 | 0.11 | pmol/sample |
| - | TG(44:1) | KDO+ATP+PLDi | 1.0 | BCD110605C27 | 0.07 | pmol/sample |
| - | TG(44:1) | KDO+ATP+PLDi | 1.0 | BCD110605C26 | 0.87 | pmol/sample |
| - | TG(44:1) | KDO+ATP+PLDi | 20.0 | BCD110605C61 | 1.72 | pmol/sample |
| - | TG(44:1) | KDO+ATP+PLDi | 20.0 | BCD110605C62 | 0.2 | pmol/sample |
| - | TG(44:1) | KDO+ATP+PLDi | 20.0 | BCD110605C63 | 0.3 | pmol/sample |
| - | TG(44:1) | KDO + ATP | 1.0 | BCD110605C15 | 0.88 | pmol/sample |
| - | TG(44:1) | KDO + ATP | 1.0 | BCD110605C14 | 3.55 | pmol/sample |
| - | TG(44:1) | KDO + ATP | 1.0 | BCD110605C13 | 21.8 | pmol/sample |
| - | TG(44:1) | KDO + ATP | 20.0 | BCD110605C49 | 0.38 | pmol/sample |
| - | TG(44:1) | KDO + ATP | 20.0 | BCD110605C50 | 0.18 | pmol/sample |
| - | TG(44:1) | KDO + ATP | 20.0 | BCD110605C51 | 0.55 | pmol/sample |
| - | TG(44:1) | KDO | 1.0 | BCD110605C08 | 2.38 | pmol/sample |
| - | TG(44:1) | KDO | 1.0 | BCD110605C07 | 0.29 | pmol/sample |
| - | TG(44:1) | KDO | 1.0 | BCD110605C09 | 3.33 | pmol/sample |
| - | TG(44:1) | KDO | 20.0 | BCD110605C45 | 1.01 | pmol/sample |
| - | TG(44:1) | KDO | 20.0 | BCD110605C44 | 1.55 | pmol/sample |
| - | TG(44:1) | KDO | 20.0 | BCD110605C43 | - | pmol/sample |
| - | TG(44:1) | C | 0.0 | BCD110605C03 | 0.04 | pmol/sample |
| - | TG(44:1) | C | 0.0 | BCD110605C01 | 0.13 | pmol/sample |